Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Molecular Therapy. Nucleic Acids|July 11, 2020
Cell Type Impacts Accessibility of mRNA to Silencing by RNA InterferenceChantal M Ferguson, Dimas Echeverria, Matthew Hassler, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 11, 2007
Oligonucleotide synthesis using ionic liquids as soluble supportsRobert A Donga, Matthew Hassler, Tak-Hang Chan, et al.
Nucleic Acids Research|December 14, 2018
Diverse lipid conjugates for functional extra-hepatic siRNA delivery in vivoAnnabelle Biscans, Andrew Coles, Reka Haraszti, et al.
Nucleic Acid Therapeutics|January 8, 2013
The 5' binding MID domain of human Argonaute2 tolerates chemically modified nucleotide analoguesGlen F Deleavey, Filipp Frank, Matthew Hassler, et al.
Nucleic Acid Therapeutics|November 27, 2023
Challenges of Assessing Exon 53 Skipping of the Human <i>DMD</i> Transcript with Locked Nucleic Acid-Modified Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular DystrophySarah Engelbeen, Daniel O'Reilly, Davy Van De Vijver, et al.
Nucleic Acid Therapeutics|October 13, 2017
Pharmacokinetic Profiling of Conjugated Therapeutic Oligonucleotides: A High-Throughput Method Based Upon Serial Blood Microsampling Coupled to Peptide Nucleic Acid Hybridization AssayBruno M D C Godinho, James W Gilbert, Reka A Haraszti, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Single intravitreal administration of a tetravalent siRNA exhibits robust and efficient gene silencing in rodent and swine photoreceptorsShun-Yun Cheng, Jillian Caiazzi, Annabelle Biscans, et al.
Plos One|August 17, 2010
Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancerPhilippe O Gannon, Jessica Godin-Ethier, Matthew Hassler, et al.
Nucleic Acids Research|February 13, 2024
A combinatorial approach for achieving CNS-selective RNAiChantal M Ferguson, Bruno M D C Godinho, Dimas Echeverria, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 20, 2024
Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's diseaseChantal M Ferguson, Samuel Hildebrand, Bruno M D C Godinho, et al.
Pageof 2